ArticlePacific Symposium on Biocomputing. Pacific Symposium on Biocomputing2023
Detection of Mild Cognitive Impairment from Language Markers with Crossmodal Augmentation.
Article in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02871921 (Internet-based Conversational Engagement Clinical Trial), which is not on this map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Internet-based Conversational Engagement Clinical Trial
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- Contrastive learning-based video quality assessment-jointed video vision transformer for video recognition.Neural computing & applications · 2026Article
- Bridging Language Markers and Pathology: Correlations Between Digital Speech Measures and Surrogate CSF Biomarkers in Alzheimer's Disease.bioRxiv : the preprint server for biology · 2025Article
- Article
- MC-ViViT: Multi-branch Classifier-ViViT to Detect Mild Cognitive Impairment in Older Adults Using Facial Videos.Expert systems with applications · 2024Article
- Bridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's disease.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
Mild cognitive impairment is the prodromal stage of Alzheimer's disease. Its detection has been a critical task for establishing cohort studies and developing therapeutic interventions for Alzheimer's. Various types of markers have been developed for detection. For example, imaging markers from neuroimaging have shown great sensitivity, while its cost is still prohibitive for large-scale screening of early dementia. Recent advances from digital biomarkers, such as language markers, have provided an accessible and affordable alternative. While imaging markers give anatomical descriptions of the brain, language markers capture the behavior characteristics of early dementia subjects. Such differences suggest the benefits of auxiliary information from the imaging modality to improve the predictive power of unimodal predictive models based on language markers alone. However, one significant barrier to the joint analysis is that in typical cohorts, there are only very limited subjects that have both imaging and language modalities. To tackle this challenge, in this paper, we develop a novel crossmodal augmentation tool, which leverages auxiliary imaging information to improve the feature space of language markers so that a subject with only language markers can benefit from imaging information through the augmentation. Our experimental results show that the multi-modal predictive model trained with language markers and auxiliary imaging information significantly outperforms unimodal predictive models.
Indexed as
Identifiers
36540960PMC9782729W4309849644What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.